Bionomics | Results Presentation Deck | 27 slides

Bionomics · 2023-03
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

27
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Problem
02
other
Open slide detailBeat · Problem
03
The slide uses a Gantt-style visualization to represent clinical trial progress.present_solution
Open slide detailBeat · Problem
04
summarize
Open slide detailBeat · Problem
05
The chart shows a reduction in alpha 2 band power when BNC210 is administered alongside nicotine compared to nicotine alone.analyze_data
Open slide detailBeat · AgitateLoop · Before After
06
The study uses a CCK-4-induced panic attack model to demonstrate Proof of Mechanism (PoM).analyze_data
Open slide detailBeat · AgitateLoop · Before After
07
The slide uses three distinct panels to show imaging and behavioral results.analyze_data
Open slide detailBeat · AgitateLoop · Before After
08
The slide uses a numbered list structure to map specific PK benefits to supporting data charts.present_solution
Open slide detailBeat · AgitateLoop · Before After
09
The chart uses a layered pie/segmentation visual to show the total addressable population vs. the specific opportunity for BNC210.size_opportunity
Open slide detailBeat · AgitateLoop · Before After
10
transition
Open slide detailBeat · Solution
11
The slide uses a numbered list format to structure the research objectives.present_framework
Open slide detailBeat · Solution
12
The slide outlines a clinical trial protocol using a process flow diagram.present_framework
Open slide detailBeat · Solution
13
The slide uses a process flow diagram to map clinical assessment timing against specific study phases.present_framework
Open slide detailBeat · Solution
14
The slide uses a dual-chart layout to contrast 'Average' vs 'AUC' metrics, highlighting the shift from primary to post-hoc analysis.analyze_data
Open slide detailBeat · Solution
15
Clinical trial data presentation showing population counts and demographic averages.analyze_data
Open slide detailBeat · Solution
16
The slide uses a line chart to demonstrate pharmacological activity in a Social Anxiety Disorder (SAD) trial.analyze_data
Open slide detailBeat · Solution
17
The slide compares a historical benchmark (Diazepam) with the company's drug (BNC210) to establish clinical relevance.present_solution
Open slide detailBeat · Solution
18
The slide uses a combination of a line chart illustrating the task phases and forest plots to show confidence intervals and p-values for various metrics.preempt_rebuttal
Open slide detailBeat · Solution
19
The slide uses a combination of a line chart showing AUC calculation and a forest plot showing differences from placebo across different dose groups.analyze_data
Open slide detailBeat · Solution
20
The slide highlights specific p-values (0.063, 0.069, 0.022, 0.023) in green boxes to emphasize statistical significance.analyze_data
Open slide detailBeat · Solution
21
The slide uses a forest plot to visualize confidence intervals and p-values for different dosage groups (225mg, 675mg, Overall) across two population segments (analyze_data
Open slide detailBeat · Solution
22
summarize
Open slide detailBeat · Solution
23
transition
Open slide detailBeat · ActionLoop · Cost Of Inaction
24
The table categorizes adverse events by relationship to study drug, severity, and system organ class.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
25
The slide uses a numbered list format to present study outcomes across seven clinical domains.summarize
Open slide detailBeat · ActionLoop · Cost Of Inaction
26
state_next_steps
Open slide detailBeat · ActionLoop · Cost Of Inaction
27
transition
Open slide detailBeat · ActionLoop · Cost Of Inaction